CCEL
CRYO CELL INTERNATIONAL INC
NASDAQ · Healthcare · Medical - Care Facilities · US
$4.65
+5.20%Year over year
Reported trailing growth
- Revenue
- -2.0%
- EBITDA
- -76.8%
- EBIT
- -95.6%
- EPS
- —
- Free cash flow
- -23.1%
- Operating cash flow
- -22.6%
Forward estimates
Based on analyst estimates
- Revenue
- -7.4%
- EBITDA
- +290.5%
- EPS
- +131.2%
Three-year CAGR
- Revenue
- +1.3%
- EBITDA
- -45.2%
- EBIT
- +6.4%
- Net income
- —
- EPS
- —
- Free cash flow
- +102.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Aug 1, 2026